IQVIA Holdings (IQV) shares surged 7.57% in pre-market trading on Tuesday following the release of its impressive second-quarter 2025 financial results and optimistic full-year guidance. The healthcare data and analytics company demonstrated robust performance across key metrics, surpassing analyst expectations.
IQVIA reported adjusted earnings per share (EPS) of $2.81 for Q2, comfortably beating the consensus estimate of $2.77. The company's revenue also exceeded expectations, coming in at $4.02 billion compared to the projected $3.96 billion. This strong top-line performance was complemented by a healthy bottom line, with net income reaching $266 million for the quarter.
Adding to the positive sentiment, IQVIA provided an upbeat outlook for the full year 2025. The company now anticipates full-year revenue in the range of $16.1 billion to $16.3 billion, and adjusted EPS between $11.75 and $12.05. Furthermore, IQVIA projected full-year adjusted EBITDA to be between $3.75 billion and $3.825 billion, highlighting the company's confidence in its operational efficiency and profitability.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。